Dapafor V 5/100 Tablet 10 is a combination medication used for the management of type 2 diabetes mellitus. It combines a DPP-4 inhibitor, which increases the levels of natural substances that help lower blood sugar when it is high, with an SGLT2 inhibitor, which helps the kidneys remove excess glucose through the urine. This dual mechanism helps improve glycemic control.
In addition to lowering blood sugar, this tablet may offer benefits for cardiovascular and renal outcomes in appropriate patients. It targets multiple pathways of diabetes management simultaneously. For best results, integrate this medicine into a routine that includes a calorie-controlled diet and regular physical activity. Monitor your hydration levels, as SGLT2 inhibitors can increase the frequency of urination.








































